Analysis Tools
normal phenotype
|
• mice are viable and fertile with no apparent defects
|
|
Allele Symbol Allele Name Allele ID |
Adam10tm1.1Khr targeted mutation 1.1, Keisuke Horiuchi MGI:5305451 |
||||||||||||||||
| Summary |
3 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice are viable and fertile with no apparent defects
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with Csf3rtm1Link homozygotes
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with Csf3rtm1Link homozygotes
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• splenocytes and bone marrow cells from pIpC-treated mice exhibit increased colony-forming units compared with control mice
|
|
• non-cell-autonomous in pIpC-treated mice
|
|
• at an early stage in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with control mice
• however, no difference was observed in the bone marrow
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• pIpC-treated mice exhibit myeloid infiltration in the spleen unlike in control mice
|
|
• severe in pIpC-treated mice with expansion of red pulp
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• metatarsal bone marrow in pIpC-treated mice is filled with hematopoietic cells instead of being replaced with fat cells as in control mice
|
|
• non-cell-autonomous in pIpC-treated mice
|
|
• non-cell-autonomous in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• at an early stage in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with control mice
• however, no difference was observed in the bone marrow
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• pIpC-treated mice exhibit myeloid infiltration in the spleen unlike in control mice
|
|
• severe in pIpC-treated mice with expansion of red pulp
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
|
• severe in pIpC-treated mice with expansion of red pulp
|
|
• in pIpC-treated mice
|
|
• in pIpC-treated mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|
|
||